The Big Interview: Novartis CTO Elizabeth Theophille

LoadingAdd to favorites

“One of our massive focuses for the up coming 4-six many years will be to refresh our SAP landscape which will involve a full overhaul…”

Pharmaceuticals’ moment in the sunshine arguably arrived with COVID-19, when an industry normally demonised as “Big Pharma” started off attracting broader recognition as a genuinely ground breaking just one that is central to fighting to the pandemic and just one which will be at the coronary heart of responding to any other upcoming community well being crises.

Pharma has drawn contemporary notice from those working in the tech sector as a final result. The plan of marrying an mental challenge with a social excellent — reverse engineering a laptop virus, and doing the exact same to a true virus to discover strategies in which to restore a method to well being is amid the clear parallels — appears to have struck a chord throughout the tech entire world a thing born out by new surveys. (The simple fact that it is a hugely worthwhile industry capable to remunerate talent well may possibly also assistance.)

That change in community sentiment was tidily captured in a study of 2,500 technologies gurus — in China, Germany, India, the Uk, and the US — by Switzerland’s Novartis, done in May and June 2020: this identified that seventy two% of tech gurus are a lot more possible to contemplate pharma for their up coming work when compared to six months back. (The study also proposed that health care and prescription drugs were now a lot more than twice as eye-catching as economical companies, telecoms and production to tech talent.)

Process operators in a thoroughly clean space. Producing facility for ground breaking cell and gene therapies in Stein, Switzerland. Credit history: Novartis

Novartis CTO: “We’re all fishing in the exact same pond”

They’re needed: throughout the sector, huge function is underway to innovate: as Bertrand Bodson, CDO of Novartis, puts it: “COVID-19 has triggered a seismic change in the adoption and scaling of electronic systems in our sector, at a speed by no means found before.”

Novartis’ Elizabeth Theophille, Head of Technologies, Architecture and Electronic (a de facto CTO position) is amid those who made the change from other sectors. Beforehand Group CIO at Nokia, she admits she realized tiny about pharma when she joined the enterprise: “I was in all probability some of the initial tranches when Novartis were looking for tech specialists that by no means experienced a health care background”, she explained to Pc Small business Assessment in a connect with.

“We’re currently being a lot more open to discover talent from other industries, mainly because we’re all fishing in the exact same pond when it comes to having excellent folks: engineers, facts experts folks that can create and architect cloud methods and assistance organization transformation.”

Speaking from Paris, she painted a picture of a diverse crew at the enterprise, working on a number of overlapping facts science, automation and cloud engineering difficulties: “I have a crew of about 300 associates. I have a massive crew of architects I have a crew of facts experts I have a crew of automation specialists: a myriad of abilities throughout my organization – and they occur from distinct backgrounds as well.”

Cloud-run innovation 

It is a massive transition for an industry very long-found as deeply conservative and risk averse. Element of that change has occur with an increasing openness to the cloud, which has aided split down inside siloes and lower technological financial debt, she indicates.

As CTO, Theophille notes: “I am also leading the architecture, structure and create of the ‘Novartis Company Information and Analytics Platform’ which is a multi-cloud system run by AWS & Azure.  This system will hold our extensive quantities of facts throughout Novartis that the organization will use for new insights and decisions…”)

“I believe a massive transformation has been all over applying cloud Platform-as-a-Support (PaaS) to create new methods we could genuinely commence to get greater insights and conclusions from the facts that we set on the cloud, whether or not that was industrial facts, advertising and marketing facts, clinical trials and so on. We’ve also been developing a whole lot a lot more consumer experience apps on the cloud. There has been a massive change in mindset [at Novartis] all over sharing facts at an enterprise stage, rather of maintaining that on your possess dedicated server. There’s a whole lot a lot more trust in in how we collaborate as an organisation.”

New (as of 2018) Novartis CEO Vasant Narasimhan has been vocal on this, and the want to make higher use of facts. The company’s 2019 yearly report [pdf] captured some of his contemplating, along with the simple fact that the organization has now collected close to two million individual many years of facts by means of clinical trials alone.

As Narasimhan noted: “We’re having measures to make the most of this strategic asset. In 2019, we expanded and released major facts and electronic initiatives though forming new collaborations to increase our escalating inside abilities.”

He additional: “We’re integrating huge quantities of facts that previously existed in silos inside of and outdoors the enterprise and having a holistic seem at it. The facts ranges from images of cells that have been treated with distinct chemical substances, to blood samples from people analyzed in clinical trials. We’re applying equipment mastering and artificial intelligence to mine the integrated, anonymized facts for connections and patterns that are indiscernible to the human mind. Our facts experts are developing products and apps that will empower Novartis teams to check with new inquiries, make greater predictions and preserve time. We can use the system to prioritize drug targets, recognize progress alternatives for compounds, and a lot more.

Novartis CTO: Supply chain arranging is a escalating section of the position

“To make obtaining of regime materials a lot more productive, we are standardizing technical specs and consolidating suppliers. The illustration of laboratory gloves illustrates our progress: We went from 100 distinct kinds of laboratory gloves worldwide to just 14, and from fifty five suppliers to just one, preserving USD .6 million. We are also developing a databases to provide a a lot more thorough look at of our acquiring and are starting up to use facts analytics to assistance us greater deal with what we invest in, when and from whom.”

That is a massive aim for CTO Elizabeth Theophille, who explained to us: “I have a massive aim right now on how we do demand arranging for supply chain how we seem at our interactions with HCPs (health care gurus) and the experience that they get, particularly when they be a part of Novartis functions. I also seem at how we simplify the way we deal with articles from a electronic asset management point of view and how we approve all of our supplies that commercially get prolonged to HCPs. And I’m just looking at how we can use technologies and organization approach to to change the way we function.”

“We have robots alive and kicking”

This contains overhauling the finance perform: “We have started off to create robots applying Microsoft Azure: applying this to basically provide jointly software package automation and to simplify quite a few of the sophisticated procedures that we have at Novartis.

“We have robots reside alive and kicking at Novartis – most of them are doing a whole lot of automation in our economical companies place. We’ve also automated the pharmacovigilance procedures exactly where, you know, we have to report adverse events”

What is the massive pending venture then?

“Every 12 months we evaluation our Technologies Outlooks based mostly on the organization strategy and new emerging tech. In my position I possess Technologies Refresh and examine new emerging technologies.  1 of our massive focuses for the up coming 4 – 6 many years will be to refresh our SAP landscape which will involve a full overhaul in organization approach transformation, technologies updates and new strategies of working…”

(CTOs and CIOs globally will recognise the head aches that can occur with this — and the temptation to go away it to previous in massive electronic transformation checklist).

“This is an remarkable time for the electronic transformation of well being care”, she concludes. “It’s actually been a amazing journey about the earlier several many years. We’ve invested a major sum of money, and [cast] partnerships with Microsoft, AWS and other organisations to assistance us rework applying their cloud technologies to analyse our facts and provide our facts jointly and to create facts science and AI products.

“The pharmaceutical industry is certainly critical to assistance people. So it’s it’s genuinely key that we get a variety of understanding and experience from other industries that can assistance us accelerate this electronic transformation.”

See also: The Huge Job interview – Former GCHQ Director Robert Hannigan